John C. Yeoman

Suggest Changes
  • Citations Per Year
Learn More
Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain. We have previously reported on a number of structurally distinct bicyclic(More)
  • 1